Citadel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$326K Buy
+14,788
New +$369K ﹤0.01% 10296
2025
Q1
Sell
-1,017
Closed -$25K 14597
2024
Q4
$25K Buy
1,017
+360
+55% +$15.7K ﹤0.01% 13029
2024
Q3
$35.4K Buy
+657
New +$35.2K ﹤0.01% 12278
2023
Q2
Sell
-1,464
Closed -$74K 14435
2023
Q1
$74K Buy
+1,464
New +$86.5K ﹤0.01% 11661
2021
Q3
Sell
-740
Closed -$229K 13868
2021
Q2
$229K Buy
+740
New +$231K ﹤0.01% 11863

Other funds holding CNBS

Citadel Advisors's CNBS Position: Q1 2026 in Review

Citadel Advisors opened a new position in Amplify Seymour Cannabis ETF (CNBS) in Q1 2026: 14,788 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #10296 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CNBS as recently as Q4 2024.

Citadel Advisors first reported a position in CNBS in Q2 2021 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold CNBS as of Q1 2026.

  • Citadel Advisors held 14,788 shares of Amplify Seymour Cannabis ETF worth $326K as of Q1 2026.
  • Amplify Seymour Cannabis ETF was a new Citadel Advisors position in Q1 2026.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10296 holding.
  • Citadel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q2 2021 and has held it in 5 quarters since.
  • 20 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.